With an aim to expand its global peptide API capacity, Cordenpharma has plans to take over Ambiopharm, a U.S.-headquartered peptide API CDMO. Ambiopharm currently has two sites, one in in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results